Drug intelligence / Profile preview

caffeine + albuterol

Development stage
Unknown
Lead developer
Pennington Biomedical Research Center
Modality
Small Molecules
Administration
Oral
01

Overview

Caffeine + albuterol is a combination of two small molecule drugs, caffeine and albuterol. Caffeine is a central nervous system stimulant that acts primarily as an adenosine receptor antagonist, increasing alertness and metabolic rate. Albuterol (also known as salbutamol) is a selective beta-2 adrenergic receptor agonist used primarily for bronchodilation in asthma and chronic obstructive pulmonary disease (COPD). The combination has been investigated for synergistic effects on body composition, specifically to reduce fat mass and increase lean body mass, with potential applications in obesity and sarcopenia. The rationale for the combination includes both agents' ability to stimulate metabolism and promote lipolysis or muscle growth through different mechanisms[5][6]. There are no widely marketed products containing this exact combination; its use remains investigational.

Other names
Albuterol and Caffeine for Adolescent Obesity
02

Targets

ADOR (Adenosine receptors)ADRB2 (β2)PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on caffeine + albuterol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on caffeine + albuterol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call